Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
Medical and Pediatric Oncology
|
December 7, 2000
Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide
C P Reynolds, Y Wang, L J Melton, et al.
The Journal of Clinical Investigation
|
September 1, 1987
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system
C J Thiele, C McKeon, T J Triche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study
R C Seeger, C P Reynolds, R Gallego, et al.
The Journal of Biological Chemistry
|
March 13, 1999
The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association
B Wang, L Feng, Y Hu, et al.
Progress in Clinical and Biological Research
|
January 1, 1982
NGF effects on human neuroblastoma lines: a model system
J R Perez-Polo, C P Reynolds, E Tiffany-Castiglioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study
K K Matthay, J B Atkinson, D O Stram, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
N-myc protein expression in small round cell tumors
T J Triche, A O Cavazzana, S Navarro, et al.
British Journal of Cancer
|
October 7, 2010
Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
W Cai, N V Maldonado, W Cui, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens
T J Moss, R C Seeger, A Kindler-Rohrborn, et al.
The American Journal of Pathology
|
August 4, 2001
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow
D S Hoon, C T Kuo, S Wen, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
Medical and Pediatric Oncology
|
December 7, 2000
Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide
C P Reynolds, Y Wang, L J Melton, et al.
The Journal of Clinical Investigation
|
September 1, 1987
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system
C J Thiele, C McKeon, T J Triche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study
R C Seeger, C P Reynolds, R Gallego, et al.
The Journal of Biological Chemistry
|
March 13, 1999
The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association
B Wang, L Feng, Y Hu, et al.
Progress in Clinical and Biological Research
|
January 1, 1982
NGF effects on human neuroblastoma lines: a model system
J R Perez-Polo, C P Reynolds, E Tiffany-Castiglioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study
K K Matthay, J B Atkinson, D O Stram, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
N-myc protein expression in small round cell tumors
T J Triche, A O Cavazzana, S Navarro, et al.
British Journal of Cancer
|
October 7, 2010
Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
W Cai, N V Maldonado, W Cui, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens
T J Moss, R C Seeger, A Kindler-Rohrborn, et al.
The American Journal of Pathology
|
August 4, 2001
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow
D S Hoon, C T Kuo, S Wen, et al.
Page
of 12